Ignite Creation Date:
2025-12-24 @ 5:23 PM
Ignite Modification Date:
2025-12-28 @ 11:38 AM
Study NCT ID:
NCT01106950
Status:
TERMINATED
Last Update Posted:
2017-12-28
First Post:
2010-04-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-07
Start Date Type:
None
Primary Completion Date:
2011-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-12
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-19
First Submit QC Date:
None
Study First Post Date:
2010-04-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-05-06
Results First Submit QC Date:
None
Results First Post Date:
2013-06-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-03
Last Update Post Date:
2017-12-28
Last Update Post Date Type:
ACTUAL